Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-19, Stock:LLY, The news for the past five days is as follows:
2019-06-12: NEWS1: Jim Cramer: A Tale of Two Stocks.NEWS2: Galapagos Ends Enrollment in Osteoarthritis Study Before Time.NEWS3: Beware the Risks in These 13 Blue-Chip Stocks.NEWS4: Beware the Risks in These 13 Blue-Chip Stocks.NEWS5: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS6: Boost Your Portfolio's Health With These 3 Big Drug Stocks.NEWS7: 5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit.NEWS8: 5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit.NEWS9: Boost Your Portfolio's Health With These 3 Big Drug Stocks.
2019-06-13: NEWS1: After Hours Most Active for Jun 13, 2019 :  GE, HAL, CZR, PG, LVS, LLY, HPE, AAPL, FLEX, CMCSA, CINF, ZNGA.NEWS2: After Hours Most Active for Jun 13, 2019 :  GE, HAL, CZR, PG, LVS, LLY, HPE, AAPL, FLEX, CMCSA, CINF, ZNGA.NEWS3: Amgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’s.NEWS4: 3 Top Diabetes Stocks to Watch in June.NEWS5: 3 Top Diabetes Stocks to Watch in June.NEWS6: Thursday Sector Laggards: Healthcare, Utilities.NEWS7: Thursday Sector Laggards: Healthcare, Utilities.NEWS8: NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag.NEWS9: NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag.NEWS10: NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag.NEWS11: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS12: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.NEWS13: Eli Lilly Broke Below the 200-Day Average to Change the Narrative to Bearish.NEWS14: Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study.
2019-06-14: NEWS1: U.S. drugmakers file lawsuit against rule requiring drug prices in TV ads.NEWS2: Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod.NEWS3: Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology.NEWS4: Drugmakers sue to stop rule requiring prices in TV ads.
2019-06-17: NEWS1: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS2: Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon.NEWS3: Pfizer Expands in Cancer With $10.6 Billion Deal for Array.NEWS4: Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth.NEWS5: Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice.
2019-06-18: NEWS1: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS2: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS3: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS4: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS5: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS6: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS7: Shares of cancer-therapy companies skyrocket after Pfizer acquisition news.

Answer: Rise